SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Manipal Health Enterprises Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

Manipal Health Enterprises Ltd

BSE: 0 NSE:
Key Metrics
Market Cap
₹0 Cr.
P/E Ratio
0.00
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Return on Capital Employed (ROCE)
13.02%
Current Price
₹0
Return on Equity (ROE)
11.79%
Return on Assets (ROA)
7.34%
Operating Profit Margin
27.2%
Net Profit Margin
17.24%
Gross Profit Margin
25.7%
Book Value per Share
₹0
Sales Growth (YoY)
14.67%
Sales Growth (3 Years)
13.56%
Operating Profit Growth (1 Year)
8.24%
Operating Profit Growth (3 Years)
21.51%
Net Profit Growth (1 Year)
59.14%
52-Week Low / High
₹0 / 0
Net Profit Growth (3 Years)
26.61%
Dividend Yield
0.00%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

DeciZen - make an informed investing decision on Manipal Health Enter

Based on:

DeciZen not available for IPO

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 8.8%6.4%4.7%6.7%10.2%5.4%14.5%10.1%13.7%13%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1,0931,2421,2971,4361,6721,4072,1202,4082,7073,1041,299
Sales YoY Gr.-13.6%4.4%10.7%16.4%-15.9%50.7%13.6%12.4%14.7%-
Adj EPS 0.70.10.10.21.20.42.42.63.423.10
YoY Gr.--81.8%16.7%35.7%515.8%-63.3%448.8%11.9%27.3%586.3%-
BVPS (₹) 1715.91616.317.217.127.829.634.4224.10
Adj Net
Profit
59.812.414.919.212043.9267299381533NAN
Cash Flow from Ops. 110231229321416390375616624644-
Debt/CF from Ops. 5.64.753.62.72.83.22.12.12.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.3%13.2%13.6%14.7%
Adj EPS 48.4%81.5%113.8%586.3%
BVPS33.2%67%100.4%552.2%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4.80.80.91.16.92.510.89.110.511.70
Op. Profit
Mgn %
16.417.117.92024.121.225.328.328.927.2NAN
Net Profit
Mgn %
5.511.11.37.23.112.612.414.117.2NAN
Debt to
Equity
0.40.70.70.70.60.60.40.40.30.4-
Working Cap
Days
13211812413913717013110175740
Cash Conv.
Cycle
-45-12-33-77-128-97-118-71-530

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 1,299 -
BVPS (₹) 0 -
Reserves (₹ Cr.) 1,583 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) -
Industry PE 86.1

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Manipal Health Enter - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1,093.451,242.221,297.201,436.271,672.181,406.762,119.562,408.192,706.953,104.10
Operating Expenses + 914.691,030.081,064.571,149.641,271.051,108.131,648.271,735.551,925.812,258.63
Manufacturing Costs55.89375.98372.62414.02121.8546.4578.7084.81682.92795.17
Material Costs260.97293.14299.80321.18357.76318.53563.74499.90531.86607.76
Employee Cost 176.80195.11203.44220.70254.03239.95305.54351.14415.59493.16
Other Costs 421.03165.85188.71193.74537.41503.20700.29799.70295.44362.54
Operating Profit 178.76212.14232.63286.63401.13298.63471.29672.64781.14845.47
Operating Profit Margin (%) 16.3%17.1%17.9%20.0%24.0%21.2%22.2%27.9%28.9%27.2%
Other Income + 65.8454.7040.9742.9250.9372.38116.9365.1194.49101.19
Exceptional Items -6.260-21.77-6.29-35.35-88.0458.65-141.88-63.200
Interest 66.03136.34135.69132.23157.29150.82185.40171.65168.41149.02
Depreciation 85.98110.83121132.95122.76128.16125.45139.35139.13148.99
Profit Before Tax 86.3319.67-4.8658.08136.663.99336.02284.87504.89648.65
Tax 30.87-14.13-21.1428.8942.3620.3872.3090.53168.53113.35
Profit After Tax 55.4633.8016.2829.1994.30-16.39263.72194.34336.36535.30
PAT Margin (%) 5.1%2.7%1.3%2.0%5.6%-1.2%12.4%8.1%12.4%17.2%
Adjusted EPS (₹)0.60.30.20.30.9-0.22.31.73.023.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1,538.991,634.961,651.651,681.051,775.461,759.213,158.863,354.313,897.845,180.63
Share Capital 60.4968.6968.6968.6968.6968.6975.6375.6375.6377.06
Reserves 1,478.501,566.271,582.961,612.361,706.771,690.523,083.233,278.683,822.215,103.57
Debt +569.511,067.801,114.521,122.181,062.121,073.051,182.161,280.911,160.651,671.54
Long Term Debt532.511,041.041,112.471,122.181,062.12975.02870.371,144.121,160.651,671.54
Short Term Debt3726.762.050098.03311.79136.7900
Minority Interest0000000000
Trade Payables74.28107.85170.50238.28261.03358.16378.24456.63433.06412.04
Others Liabilities 245.74208.66228.80266.48649.61558.941,018.99537.15723.791,105.15
Total Liabilities 2,428.523,019.273,165.473,307.993,748.223,749.365,738.255,6296,215.348,369.36

Fixed Assets

Net Fixed Assets +1,308.431,675.891,664.621,634.201,949.081,572.851,541.441,543.701,588.911,652.28
Gross Block1,614.332,037.652,146.562,248.742,6792,353.132,419.182,523.992,670.482,832.68
Accumulated Depreciation305.90361.76481.94614.54729.92780.28877.74980.291,081.571,180.40
CWIP 48.6942.1837.0851.9684.60381.43388.47374.11377.511,305.84
Investments 645.83892.52953.76963.711,030.271,114.612,937.153,202.123,390.914,635.67
Inventories30.7832.7626.3426.0927.1513.8437.4516.0630.9527.65
Trade Receivables94.12106.71108.48117.8896.0484.85158.40127.64133.38190.74
Cash Equivalents 8.3519.8819.2554.0437.5215.5120.4728.61227.93149.57
Others Assets 292.32249.33355.94460.11523.56566.27654.87336.76465.75407.61
Total Assets 2,428.523,019.273,165.473,307.993,748.223,749.365,738.255,6296,215.348,369.36

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 110.25231.01228.65320.70415.58390.47375.49616623.69644.28
PBT 86.3319.67-4.8658.08136.663.99336.02284.87504.89648.65
Adjustment 47.03207.14240.15243.78269.69200.55196.67394.02298.83242.29
Changes in Working Capital -38.9211.5728.2360.8349.13114.48-103.1563.71-26.03-91.89
Tax Paid -47.19-7.37-34.87-41.99-39.9071.45-54.05-126.60-154-154.77
Cash Flow From Investing Activity + -180.92-381.50-165.44-177.87-252.45-212.81-1,465.32-511.21-405-1,851.58
Capex 201.03-211.1377.94352.64-131.03-74.10-67.11-139.53-142.93-703.56
Net Investments -131.34-106.17-140.56-391.680-10.68-65.65-278.70-146.04-198.43
Others -250.61-64.20-102.82-138.83-121.42-128.03-1,332.56-92.98-116.03-949.59
Cash Flow From Financing Activity + 57.03197.29-37.67-106.92-177.55-198.491,094.80-96.65-19.371,107.19
Net Proceeds from Shares 0000001,136.7800750
Net Proceeds from Borrowing 00000-56.210000
Interest Paid -60.87-126.77-124.69-118.81-30.44-106.56-128.71-31.56-144.16-136.49
Dividend Paid 0000000000
Others 117.90324.0687.0211.89-147.11-35.7286.73-65.09124.79493.68
Net Cash Flow -13.6446.8025.5435.91-14.42-20.834.978.14199.32-100.11

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)4.412.130.991.755.46-0.9310.725.979.2811.79
ROCE (%)8.796.394.746.7410.25.3814.4810.1313.6513.02
Asset Turnover Ratio0.560.460.420.440.470.380.450.420.460.43
PAT to CFO Conversion(x)1.996.8314.0410.994.41N/A1.423.171.851.2
Working Capital Days
Receivable Days25303029232321221819
Inventory Days9987654433
Payable Days86113169232255355238305305254

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Manipal Health Enterprises Ltd FAQs

The current trading price of Manipal Health Enter on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Manipal Health Enter stood at ₹0.00 Cr

The latest P/E ratio of Manipal Health Enter as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Manipal Health Enter as of 31-Dec-1969 is 0.00.

The 52-week high of Manipal Health Enter is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Manipal Health Enter is ₹1,299 ( Cr.) .

About Manipal Health Enterprises Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×